food and drug administration

Order byBest matchMost fresh

FDA reverses ban on Juul's e-cigarette sales

FDA approves Juul e-cigarette and cartridge sales

Officials with the Food and Drug Administration have approved the continued sales of tobacco-flavored e-cigarettes and refill cartridges by Juul Labs.

· 1d · on MSN

Juul gets FDA’s OK to keep selling tobacco and menthol e-cigarettes

· 12h

FDA Approves Juul E-Cigs for Sale, Years After Ban Attempt

· 12h

FDA makes Juul’s reign official

The FDA authorized Juul’s applications on Thursday to sell e-cigarettes in the U.S., determining they’re “appropriate for the protection of public health” because their benefits to adult smokers of c...

· 1d

F.D.A. Approves Juul Vapes After Yearslong Delay

· 1d

US FDA Approves Juul's E-Cigarettes, Source

· 1d

FDA reverses ban on sale of Juul e-cigarettes

“Today’s FDA authorization of JUUL products marks an important step toward making the cigarette obsolete,” K.C. Crosthwaite, Juul Labs’s CEO, said in a statement.

· 1d

Juul can continue selling its tobacco and menthol e-cigarettes, FDA says

FOX 29 · 15h

Juul gets FDA approval to keep selling e-cigarettes

12h

Health Cuts Would Result in Fewer Drugs for Americans, Budget Office Reports

The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising medications, the Congressional Budget Office said on Friday.

10hon MSN

CBO finds health agency cuts would result in fewer new drugs

The Trump administration’s proposed cuts at the National Institutes of Health and Food and Drug Administration could lower the number of new drugs that come to market in the next three decades, according to an analysis released Friday by the Congressional Budget Office.

8hon MSN

Congressional forecaster says Trump health research cuts would lead to fewer new drugs

President Donald Trump's proposed budget cuts to the National Institutes of Health would eventually result in fewer drugs on the market, the U.S. Congressional Budget Office said on Friday.

2don MSN

FDA to end dozens of 'obsolete' rules for U.S. food items

The U.S. government is nixing a whole slew of "obsolete" U.S. food standards that Trump administration officials say also include "unnecessary" ones.

11h

GSK's Blood Cancer Drug Faces US Setback Due To FDA Panel's Eye Safety Warning

Oncologic Drugs Advisory Committee (ODAC) voted against the overall benefit/risk profile at the proposed dosage of GSK plc’s (NYSE:GSK) Blenrep (belantamab mafodotin-blmf) combinations. The belantamab mafodotin combinations were evaluated in adults with relapsed or refractory multiple myeloma who have received at least one prior line of therapy.

15h

Closing the loophole: updates on federal and state attempts to regulate intoxicating hemp-derived products

Gonnell and Cole White of Troutman Pepper Locke LLP outline federal and state developments related to the regulation of intoxicating hemp-derived products, including addressing a perceived loophole in the 2018 Farm Bill.

21hon MSN

GSK Falls After FDA Advisory Panel Fails to Back Cancer Drug

GSK Plc shares tumbled after its blood cancer drug failed to secure the backing of a panel of US regulatory advisers, putting its approval in doubt.

15h

The FDA Announces Recall on Bread Sold at Walmart and Kroger in These States

Lewis Bake Shop is issuing a voluntary recall on their Artisanal Style 1/2 Loaf, which contains undisclosed hazelnuts — a danger to those with a sensitivity.

STAT18h

FDA advisers say risks of GSK blood cancer drug outweigh benefits in surprise setback

FDA advisers on Thursday voted against GSK's blood cancer drug Blenrep, finding that its risks outweighed its benefits at the selected dose

3don MSN

FDA approves new blue food dye derived from gardenia fruit

The U.S. Food and Drug Administration approved a new blue color additive derived from the fruit of the gardenia, a flowering evergreen, for use in a variety of drinks and candies.

TAG24 on MSN1d

Food and Drug Administration may soon revise hormone replacement therapy warnings

US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels on Hormone Replacement Therapy.